OmniStar Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

OmniStar Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,628	Closed	-$1.31M	–	121
2021 Q2	$1.31M	Buy	+19,628	New	+$1.28M	1.62%	15
2018 Q4	–	Sell	-4,655	Closed	-$302K	–	106
2018 Q3	$302K	Buy	+4,655	New	+$276K	0.23%	123

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

OmniStar Financial Group's BMY Position: Q2 2026 in Review

OmniStar Financial Group increased its Bristol-Myers Squibb (BMY) stake by 8% in Q2 2026, buying an estimated $249K and bringing the position to 58,507 shares worth $3.37M. The position accounts for 1.55% of the portfolio, ranked #16.

OmniStar Financial Group first reported a position in BMY in Q3 2018 and has held it in 27 quarters since. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

OmniStar Financial Group held 58,507 shares of Bristol-Myers Squibb worth $3.37M as of Q2 2026.
OmniStar Financial Group bought 4,345 Bristol-Myers Squibb shares in Q2 2026, an estimated $249K.
Bristol-Myers Squibb made up 1.55% of OmniStar Financial Group's portfolio in Q2 2026, its #16 holding.
OmniStar Financial Group first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 27 quarters since.
936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.